Allergan, Inc.
NYSE: AGN
$193.02
+$0.03 (+0.0%)
Closing Price on May 8, 2020
AGN Stock Chart and Intraday Price
AGN Stock Data
| Asset Type | ETF |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drugs |
AGN Articles
Some mergers can add a nice shot in the arm for an acquirer. After years of being focused on Humira, AbbVie has now completed its acquisition of Allergan.
Published:
These three health care companies included are expected to report their earnings on Tuesday morning.
Published:
Wednesday's top analyst upgrades, downgrades and initiations included Amazon.com, Boeing, Broadcom, Cisco Systems, IBM, Netflix, Rio Tinto, Tesla, Verizon, Visa and Xerox.
Published:
The FDA has approved Allergan's treatment for migraines in adults. The drug is the first of its class to obtain FDA approval, but the new drug will compete with other recently released treatments for...
Published:
Tuesday's top analyst upgrades, downgrades and initiations included AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack and T-Mobile.
Published:
Here are 20 companies that should offer investors who are retired or near retirement some added income to help make their golden years safe and sound.
Published:
Allergan has finally announced that its shareholders have voted to approve the company’s acquisition of AbbVie. The acquisition is expected to close in early 2020, but it is still subject to...
Published:
Five drugmakers are considering a proposal that would have them contribute to a trust established as part of the bankruptcy settlement by Purdue Pharmaceuticals and be released from liability in the...
Published:
Shares of drugmaker Mallinckrodt have lost more than 40% overnight following reports that the firm has hired restructuring advisors. A bankruptcy filing is a real possibility.
Published:
The top analyst upgrades, downgrades and initiations on Thursday included Advanced Micro Devices, Apple, Chipotle Mexican Grill, Costco, Exxon Mobil, Netflix, Qualcomm, Ulta Beauty and U.S. Bancorp.
Published:
The top analyst upgrades, downgrades and initiations seen on Tuesday included AFL, Agilent, Allergan, Barrick Gold, Cognex, Hilton, Lloyds, MetLife, Slack and Wingstop.
Published:
Allergan shares jumped on Tuesday after the company announced that it would be acquired by AbbVie in a cash and stock transaction valued at roughly $63 billion.
Published:
The top analyst upgrades, downgrades and initiations on Tuesday included Agilent Technologies, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec,...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday included 3D Systems, Allergan, Alcon, Booking, GoPro, IAC/Interactive, Lowe's and Yelp.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday included Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra Energy, Peabody Energy, Teva Pharmaceutical and...
Published:
Last Updated:
